Next Post

CureApp: World’s First Medical Device Regulatory Approval of Digital Therapeutic App for Hypertension | Region

TOKYO–(BUSINESS WIRE)–May 5, 2022– CureApp, Inc. (Head Office: Chuo-ku, Tokyo; CEO: Kohta Satake) was notified by the Ministry of Health, Labour and Welfare on April 26, 2022 that the company had received the medical device regulatory approval of an digital therapeutic app for Hypertension. This marks the first time a […]